Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07092111 | Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer | unknown | N/A | 110 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT06955156 | Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC | unknown | Phase 2 | 50 | QIAO LIOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT04097366 | Breast Screening - Risk Adaptive Imaging for Density(BRAID) | unknown | N/A | 9,000 | University of CambridgeOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT05628870 | A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer | unknown | Phase 1 | 102 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | Mar 17, 2025 | clinicaltrials |
| NCT05992870 | Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction | unknown | N/A | 40 | Hubei Cancer HospitalOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT06497660 | Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia | unknown | Phase 4 | 496 | Fujian Medical University Union HospitalOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06857747 | Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer. | unknown | N/A | 40 | QIAO LIOTHER | 0 | Mar 4, 2025 | clinicaltrials |
| NCT06702800 | Clinical Exploratory Study on Predicting Drug Sensitivity for Breast Cancer Treatment Using Simulated Organoid Models. | unknown | — | 30 | Xiangya Hospital of Central South UniversityOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study(INSPIRE) | unknown | — | 5,350 | Singlera Genomics Inc.INDUSTRY | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06496724 | A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer | unknown | N/A | 1 | JIANG LONGWEIOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06311357 | Percent Weight Change in the Medical Supplement Group of Early Breast Cancer | unknown | N/A | 40 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06470672 | Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer | unknown | Phase 2 | 32 | Fudan UniversityOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | unknown | Phase 1 | 48 | Carisma Therapeutics IncINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06729814 | Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fractions Radiation Therapy | unknown | — | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06724835 | Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T) | unknown | Phase 1 | 18 | Shenzhen Celconta Life Science Co., Ltd.INDUSTRY | 1 | Dec 9, 2024 | clinicaltrials |
| NCT04551495 | Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)(ROSALINE) | unknown | Phase 2 | 65 | Jules Bordet InstituteOTHER | 2 | Dec 4, 2024 | clinicaltrials |
| NCT06143553 | Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer | unknown | Phase 3 | 168 | Shanghai Yizhong Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 29, 2024 | clinicaltrials |
| NCT06678230 | Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | 40 | The First Hospital of Jilin UniversityOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT06663228 | Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | unknown | Phase 1 / Phase 2 | 179 | NGM Biopharmaceuticals, IncINDUSTRY | 3 | Oct 2, 2024 | clinicaltrials |
| NCT06621459 | Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)(MONARCHE29) | unknown | — | 30 | University Hospital, BrestOTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT06608043 | Reborn Lifestyle Adjustment Program | unknown | — | 60 | Atlas UniversityOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT06598046 | A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC | unknown | Phase 2 | 48 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05099978 | Asian Multicenter Prospective Study of ctDNA Sequencing(A-TRAIN) | unknown | — | 506 | National Cancer Center, JapanOTHER_GOV | 8 | Sep 4, 2024 | clinicaltrials |
| NCT06578988 | Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting | unknown | — | 25,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT00080756 | Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease | unknown | Phase 2 | 11 | City of Hope Medical CenterOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT05447988 | Motiva Flora Tissue Expander PMCF | unknown | N/A | 136 | Establishment LabsINDUSTRY | 4 | Aug 27, 2024 | clinicaltrials |
| NCT06347354 | Permanence of Indocyanine Green in Axillary Lymph Nodes 3 Weeks After Subdermal Injection in Patients With Breast Cancer and Metastatic Lymph Nodes(FLUO) | unknown | N/A | 10 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06572410 | Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision | unknown | — | 200 | Elucent MedicalINDUSTRY | 1 | Aug 27, 2024 | clinicaltrials |
| NCT05830097 | A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 260 | Coherent Biopharma (Hefei) Co., Ltd.INDUSTRY | 2 | Aug 26, 2024 | clinicaltrials |
| NCT06471673 | A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer | unknown | Phase 1 / Phase 2 | 18 | BriaCell Therapeutics CorporationINDUSTRY | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06224387 | CTS2190 Phase I /II Clinical Study in Patients | unknown | Phase 1 / Phase 2 | 224 | CytosinLab Therapeutics Co., Ltd.INDUSTRY | 1 | Aug 23, 2024 | clinicaltrials |
| NCT05887102 | Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors(PACHA) | unknown | N/A | 66 | CHU de Quebec-Universite LavalOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT03748550 | Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)(EXACT2) | unknown | N/A | 7 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05689112 | Microscopy Imaging of Whole-mount Stained Human Tissues | unknown | — | 250 | National Taiwan University HospitalOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05972785 | Long-term Use of CCB and Breast Cancer Risk | unknown | — | 68,500 | Curtin UniversityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05169853 | Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer | unknown | — | 80 | Ain Shams UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06561022 | Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping(abemaSNF1/3) | unknown | Phase 2 | 260 | Fudan UniversityOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT06116812 | The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction (MBSR) Practices Applied to Women With Breast Cancer | unknown | N/A | 105 | Kafkas UniversityOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06486155 | Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining | unknown | — | 2,200 | Yunnan Cancer HospitalOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06510738 | Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images | unknown | — | 700 | Yunnan Cancer HospitalOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06006390 | CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06544577 | Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC | unknown | — | 350 | SciClone PharmaceuticalsINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06544668 | A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases | unknown | — | 3,500 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06494865 | " Role of Diffusion Weighted Image in the Diagnosis and Follow up of Breast Cancer" | unknown | — | 30 | Sohag UniversityOTHER | 0 | Aug 7, 2024 | clinicaltrials |
| NCT06541587 | Smart VR Mindfulness for Breast Cancer: Integrating Biofeedback and Evaluating Chemotherapy Effectiveness | unknown | N/A | 60 | Hsin Yi LuOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT02991677 | Exercise Effect on Chemotherapy-Induced Neuropathic Pain | unknown | N/A | 60 | Baltimore VA Medical CenterFED | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06539559 | Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer | unknown | Phase 2 | 60 | Wang JiayuOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT05963464 | RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)(RADIOSO) | unknown | — | 300 | European Institute of OncologyOTHER | 1 | Aug 5, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jul 29, 2025source: clinicaltrials